Fight CRC Clinical Trial Finder
| NCT ID | Title | 阶段 | Date Added | 地点 | Prior IO Allowed | CRC-directed | Status | 药物 | 标签 |
|---|---|---|---|---|---|---|---|---|---|
| NCT ID NCT06493760 |
TitleA Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients | 阶段
第二阶段
|
Date Added 2024-07-10 |
地点
中国
|
Prior IO Allowed 没有 |
CRC-directed 是 |
Status
招聘
|
药物 |
标签
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT03600883 |
TitleA Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100) | 阶段
Phase 1, Phase 2
|
Date Added 2018-07-26 |
地点
California, United States
Colorado, United States Connecticut, United States Delaware, United States Florida, United States Georgia, United States Indiana, United States Maryland, United States Massachusetts, United States Michigan, United States Missouri, United States New York, United States North Carolina, United States Ohio, United States Pennsylvania, United States South Carolina, United States Tennessee, United States Texas, United States Utah, United States Virginia, United States Washington, United States 澳大利亚 Austria 比利时 巴西 加拿大 法国 德国 希腊 Hungary 日本 大韩民国 葡萄牙 Romania 西班牙 瑞士 |
Prior IO Allowed 是 |
CRC-directed 没有 |
Status
活跃，非招募
|
药物
Anti PD-1/L1, Midazolam, Sotorasib |
标签
MSS/ MMRp
|
| NCT ID NCT06055439 |
Title评估自体钙粘蛋白 17 嵌合抗原受体 (CAR) T 细胞疗法 CHM-2101 的 1/2 期研究 | 阶段
Phase 1, Phase 2
|
Date Added 2023-09-26 |
地点
Georgia, United States
Illinois, United States Pennsylvania, United States Tennessee, United States |
Prior IO Allowed 是 |
CRC-directed 是 |
Status
招聘
|
药物 |
标签
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT06011772 |
TitleA Phase 0 Study of EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer | 阶段
早期阶段 1
|
Date Added 2023-08-25 |
地点
New York, United States
|
Prior IO Allowed 是 |
CRC-directed 是 |
Status
暂停
|
药物
fluorouracil, Irinotecan, Leucovorin, oxaliplatin |
标签
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT06412198 |
TitleA Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations | 阶段
Phase 1, Phase 2
|
Date Added 2024-05-14 |
地点
Massachusetts, United States
Texas, United States |
Prior IO Allowed 没有 |
CRC-directed 是 |
Status
招聘
|
药物
Adagrasib, cemiplimab, cetuximab |
标签
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT05865535 |
TitleA Dose Escalation Study of AV-380 in Metastatic Cancer Patients With Cachexia | 阶段
第 1 阶段
|
Date Added 2023-05-19 |
地点
California, United States
Florida, United States Georgia, United States Nebraska, United States New York, United States Oregon, United States South Carolina, United States Tennessee, United States Texas, United States |
Prior IO Allowed 没有 |
CRC-directed 没有 |
Status
招聘
|
药物 |
标签
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT06010901 |
TitleA Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer. | 阶段
第 1 阶段
|
Date Added 2023-08-25 |
地点
中国
|
Prior IO Allowed 是 |
CRC-directed 是 |
Status
招聘
|
药物
Anlotinib hydrochloride capsules, Penpulimab Injection, TQB2618 injection |
标签
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT05973487 |
TitleA Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors | 阶段
第 1 阶段
|
Date Added 2023-08-03 |
地点
Arizona, United States
California, United States Connecticut, United States Florida, United States Illinois, United States Kentucky, United States Michigan, United States Minnesota, United States New York, United States North Carolina, United States Ohio, United States Oklahoma, United States Oregon, United States Pennsylvania, United States Tennessee, United States Texas, United States |
Prior IO Allowed 是 |
CRC-directed 是 |
Status
招聘
|
药物 |
标签
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT06856837 |
Title– IKF/AIO-QUINTIS – Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases | 阶段
第二阶段
|
Date Added 2025-03-04 |
地点
Austria
德国 |
Prior IO Allowed 没有 |
CRC-directed 是 |
Status
尚未招聘
|
药物 |
标签
MSS/ MMRp
|
